In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 88 for your search:
Drug:  therapeutic allogeneic lymphocytes
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: CRUK-EBV-CTL, LCMV-CTL, EU-20057, NCT00033475

2.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: 557, U01HL072268, HL072268, HL072291, HL072196, HL072248, HL072191, HL072305, HL072028, HL072072, HL072355, HL072283, HL072346, HL072331, HL072290, NCT00627393

3.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 75 and under
Sponsor: NCI, Other
Protocol IDs: 1655.00, NCI-2009-01471, P01CA018029, FHCRC-1655.00, 5430, NCT00052520

4.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 1803.00, NCI-2010-00163, P30CA015704, P01CA078902, FHCRC-1803.00, 5606, NCT00068718

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: NCI, Other
Protocol IDs: CDR0000370797, CALGB-100102, NCT00085449

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: FHCRC-1135.00

7.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: 2004LS042, UMN-MT2003-23, UMN-IRB-0405M60481, UMN-2004LS042, NCT00303667

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 65
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: GCLLSG-CLL3X, EU-20554, MEDAC-FLUD.10/CLL, NCT00281983

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 70 and under
Sponsor: Other
Protocol IDs: 2005-0508, NCI-2012-01484, 1PO1CA100265, NCT00402558

10.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: Other
Protocol IDs: EK126092000, NCT00460629

11.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 55
Sponsor: NCI, Other
Protocol IDs: LCCC 0510, P30CA016086, CDR0000550145, UNC-LCCC-0510, NCT00448357

12.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ITL-001-HMC, NCT00558675

13.

Phase: Phase II, Phase I
Type: Supportive care
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: 22994-CHALLAH, CHALLAH, U54HL081007, NCT00711035

14.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 15 to 75
Sponsor: Other
Protocol IDs: CDR0000632275, AMC-UUCM-2008-0383, 2008-0383, NCT00823524

15.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 1380.00, FHCRC-1380.00, NCI-H00-0057, CDR0000067777, NCT00005802

16.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: Under 75
Sponsor: NCI, Other
Protocol IDs: 1495.00, NCI-2012-00581, P30CA015704, FHCRC-1495.00, NCI-G00-1790, NCT00005851

17.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: Under 75
Sponsor: NCI, Other
Protocol IDs: 1533.00, NCI-2013-01634, P01CA078902, P30CA015704, FHCRC-1533.00, NCI-H00-0062, NCT00006251

18.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 1 to 74
Sponsor: NCI
Protocol IDs: 080051, 08-C-0051, NCT00923910

19.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 75 and under
Sponsor: NCI, Other
Protocol IDs: 1586.00, FHCRC-1586.00, NCI-H01-0080, CDR0000069042, NCT00027547

20.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 1641.00, NCI-2012-00591, P01CA018029, P30CA015704, FHCRC-1641.00, NCI-H01-0081, NCT00027820

21.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: NCI, Other
Protocol IDs: 1743.00, NCI-2011-00386, P30CA015704, FHCRC-1743.00, 5476, NCT00054353

22.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 69
Sponsor: Other
Protocol IDs: 1838.00, FHCRC-1838.00, CDR0000430694, NCT00248430

23.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065938, ECOG-E1A97, E1A97, NCT00003153

24.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 10 to 80
Sponsor: NHLBI
Protocol IDs: NHLBI-99-H-0064, NCT00003839

25.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: NCI, Other
Protocol IDs: 9672, UCCRC-9672, UCCRC-CTRC-9866, NCI-G99-1612, NCT00004135
1     
New Search